Prof. Vincent Brandenburg, MD
Zentrum für Innere Medizin
Mauerfeldchen 25
52146 Würselen
+49 2405 620
Vincent Brandenburg is nephrologist and head of the department of nephrology at the Rhein-Maas Klinikum in Würselen, Germany. His major clinical fields of interest are chronic kidney disease – mineral and bone disorder (CKD-MBD) including calciphylaxis, heart failure and cardiovascular disease associated with CKD. He was associate professor and senior consultant at the Department of Cardiology, University Hospital of the RWTH Aachen, Germany until 2018. In this position he was Consultant for the Intermediate Care Unit and Heart Failure outpatient clinic. Dr Brandenburg gained his medical degree in 1998 at the RWTH Aachen and the Ludwig-Maximilians University Munich, Germany. In 2005, he completed a two-years postdoctoral research period at the IZKF BioMAT, also at the University Hospital Aachen on the subject of the mechanism of extraosseous calcification in uremia. Dr Brandenburg then became a nephrologist at the Department of Nephrology, University Hospital Aachen (Head: Professor Jürgen Floege, MD) until 2009 before he started completing his educational program at the cardiology department. Dr Brandenburg is conducting clinical research on the pathophysiology and treatment of renal osteodystrophy, bone disease after renal transplantation, and cardiovascular calcification in chronic kidney disease. His basic research interests are mechanisms of cardiovascular disease in uremia with particular focus upon vitamin K and oral anticoagulation. He is currently also conducting research about the role of alkaline phosphatase, fetuin-A, FGF23, cardiovascular effects of vitamin D and Wnt/beta-catenin signalling in the bone-vascular axis in uremia. He was also board member of the ERA-EDTA scientific working group “CKD-MBD” until 2017. A major research target is calciphylaxis. As such, he is currently initiating a multinational European calciphylaxis registry “EuCalNet” for which he is principal investigator ( Prof. Brandenburg is also principal investigator of several prospective human intervention trials investigating interventions against cardiovascular calcification progression. The clinical focus is the chronic cardio-renal syndrome. Dr Brandenburg has authored or co-authored over 160 articles in peer reviewed journals. He is member of the German and European societies of nephrology and the societies of cardiology. In 2018, he received the Nils-Alwall award from the German Society of Nephrology for his ongoing fight against calciphylaxis.